Daehong Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daehong Cho has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ae-Rin Baek
Division of Allergy and Pulmonology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
1 shared publication - Cheol-Woo Kim
Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
1 shared publication - Chi Ryang Chung
Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication - Ganghee Chae
Affiliation Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
1 shared publication - Gil Myeong Seong
Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
1 shared publication - Hong Jun Kim
Department of Neurology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (38) , e249
Pulmonary Fibrosis in Critically Ill Patients With COVID-19: A Multi-Center Retrospective Cohort Study in Korea
Cho D, et al. J Korean Med Sci. 2025 Aug;40:e249. https://doi.org/10.3346/jkms.2025.40.e249
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (38) , e249
Open AccessPulmonary Fibrosis in Critically Ill Patients With COVID-19: A Multi-Center Retrospective Cohort Study in Korea
Cho D, et al. J Korean Med Sci. 2025 Aug;40:e249. https://doi.org/10.3346/jkms.2025.40.e249
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Critical Care
- Vol. 2025 (1) , 3211626
Reversible Severe Acute Lactic Acidosis Caused by Thiamine Deficiency in Intensive Care Unit
Lactic acidosis is a common cause of metabolic acidosis in hospitalized patients. It is typically caused by hypoperfusion and anaerobic metabolism and is often associated with sepsis. However, it can also result from impaired lactate metabolism, independent of hypoxemia. We report the case of a 50‐year‐old woman with severe lactic acidosis who was admitted to the intensive care unit. Lactic acidosis was initially attributed to an uncontrolled infection. However, brain magnetic resonance imaging revealed Wernicke’s encephalopathy due to thiamine deficiency. The administration of high‐dose intravenous thiamine rapidly improved the mental status and normalized serum lactate levels. This case highlights the importance of identifying thiamine deficiency as a reversible cause of lactic acidosis in critically ill patients.
- 1 January 2025
- Published by Wiley in Case Reports in Critical Care
- Vol. 2025 (1) , 3211626
Open AccessReversible Severe Acute Lactic Acidosis Caused by Thiamine Deficiency in Intensive Care Unit
Lactic acidosis is a common cause of metabolic acidosis in hospitalized patients. It is typically caused by hypoperfusion and anaerobic metabolism and is often associated with sepsis. However, it can also result from impaired lactate metabolism, independent of hypoxemia. We report the case of a 50‐year‐old woman with severe lactic acidosis who was admitted to the intensive care unit. Lactic acidosis was initially attributed to an uncontrolled infection. However, brain magnetic resonance imaging revealed Wernicke’s encephalopathy due to thiamine deficiency. The administration of high‐dose intravenous thiamine rapidly improved the mental status and normalized serum lactate levels. This case highlights the importance of identifying thiamine deficiency as a reversible cause of lactic acidosis in critically ill patients.
- Open Access
- 30 September 2024
- Published by Jeju National University Institute for Medical Science in Journal of Medicine and Life Science
- Vol. 21 (3) , 83-91
Adverse drug reactions reported over 5 years in a regional university hospital
Adverse drug reactions (ADRs) are closely associated with increased morbidity and mortality rates, prolonged hospitalization durations, and higher healthcare costs. This study aimed to estimate the incidence, clinical features, and reporting status of ADRs to improve the current ADR reporting system and prevent recurrent ADRs in hospitals. This retrospective study was conducted at a regional referral hospital. Patients diagnosed with ADRs over a 5-year period (2009-2014) were recruited for this study. An ADR was identified as an ADRrelated diagnosis in a patient’s medical record or an ADR registered through the inhospital ADR reporting system. The incidence, culprit drug, clinical manifestations, reporting source, severity, related management, and recurrence rate were assessed. Among 1,112 patients, 1,375 ADR events were collected, an estimated 0.06% of the total number of patient visits. Diagnostic contrast agents (46.4%) were the most common culprit drugs, followed by antibiotics (22.0%), nonsteroidal anti-inflammatory drugs (9.9%), and opioids (4.5%). Skin reactions (67.5%) such as rashes and hives were the most frequent manifestations. Additional ADR-related medical attention was necessary in two thirds of cases. One hundred eighty ADR events (13.1%) were categorized as severe, and 19 patients (1.4%) experienced re-exposure to the culprit drugs. Four patients (0.3%) experienced fatal ADRs. Physicians were the most frequent ADR reporters in the in-hospital ADR reporting system. In conclusion, many ADR events may be overlooked, and re-exposure to causative drugs commonly occurs. Continuous education and maintenance of a reporting system may be important for preventing recurrent ADRs.
- 30 September 2024
- Published by Jeju National University Institute for Medical Science in Journal of Medicine and Life Science
- Vol. 21 (3) , 83-91
Open AccessAdverse drug reactions reported over 5 years in a regional university hospital
Adverse drug reactions (ADRs) are closely associated with increased morbidity and mortality rates, prolonged hospitalization durations, and higher healthcare costs. This study aimed to estimate the incidence, clinical features, and reporting status of ADRs to improve the current ADR reporting system and prevent recurrent ADRs in hospitals. This retrospective study was conducted at a regional referral hospital. Patients diagnosed with ADRs over a 5-year period (2009-2014) were recruited for this study. An ADR was identified as an ADRrelated diagnosis in a patient’s medical record or an ADR registered through the inhospital ADR reporting system. The incidence, culprit drug, clinical manifestations, reporting source, severity, related management, and recurrence rate were assessed. Among 1,112 patients, 1,375 ADR events were collected, an estimated 0.06% of the total number of patient visits. Diagnostic contrast agents (46.4%) were the most common culprit drugs, followed by antibiotics (22.0%), nonsteroidal anti-inflammatory drugs (9.9%), and opioids (4.5%). Skin reactions (67.5%) such as rashes and hives were the most frequent manifestations. Additional ADR-related medical attention was necessary in two thirds of cases. One hundred eighty ADR events (13.1%) were categorized as severe, and 19 patients (1.4%) experienced re-exposure to the culprit drugs. Four patients (0.3%) experienced fatal ADRs. Physicians were the most frequent ADR reporters in the in-hospital ADR reporting system. In conclusion, many ADR events may be overlooked, and re-exposure to causative drugs commonly occurs. Continuous education and maintenance of a reporting system may be important for preventing recurrent ADRs.